Skip to content

Natraderm Info

Narrow screen resolution Wide screen resolution Increase font size Decrease font size Default font size
Home arrow News Feeds
Health News Feeds
Allergy News From Medical News Today
Latest Allergy News From Medical News Today.

  • Immune System Pathway Identified To Fight Allergens, Asthma
    For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according to a study reported in the May edition of the journal Nature Medicine.

  • House Of Lords To Debate Science Committee Allergy Report, UK
    The House of Lords will on Thursday 8 May debate the Science and Technology Committee's report on Allergy which was published in September last year. The Government responded to the report in November and accepted many of the Committee's recommendations. The debate will give the Committee the opportunity to question the Government on how far they have got in implementing these recommendations.

  • On The Road With Allergies And Asthma
    For millions of Americans with allergies and asthma, summer travel concerns extend far beyond rising gas prices and airline security waits.The American Academy of Allergy, Asthma & Immunology (AAAAI) estimates that more than 20 million Americans have asthma and 50 million have allergies. Those traveling this summer will face unique challenges."Vacations bring people outdoors to explore new sights or enjoy the weather.

  • April Showers Bring May Flowers... And Kick Allergy Season Into Full Bloom
    May is National Asthma and Allergy Awareness Month, and Carpenter Co., a leader in sleep technologies and the world's largest producer of comfort cushion products, offers relief for the more than 60 million Americans who suffer from these ailments. The company's innovative SlumberFresh? pillow is filled with RELY? fiber, which protects the pillow and mattress pad against known allergens such as mold, mildew, fungus and the odors they cause.

  • Peanut Allergy Immunotherapy Should Be Available In Five Years
    Some form of immunotherapy is expected to be available for peanut allergy within the next five years. But the reasons for the increasing prevalence of this allergic reaction remain unclear. The issues are discussed by Professor Wesley Burks, Duke University Medical Center, NC, USA, in a Seminar in this week's edition of The Lancet.

  • ISTA Pharmaceuticals Announces New Phase III Clinical Findings To Support Bepreve NDA Filing
    ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from the preliminary analysis of its second and final Bepreve(TM) (bepotastine ophthalmic solution) Phase III clinical study. The U.S. multi-center conjunctival allergen challenge (CAC) study evaluated the onset and duration of effect of two Bepreve concentrations in 130 patients with a history of ocular allergies.

  • Lexington Is USA's Worst City For Allergy Sufferers
    According to the Asthma and Allergy Foundation of America (AAFA), Lexington, Kentucky, is the worst city for allergy sufferers in the USA. The AAFA has issued the 2008 Rank - Rankings for the Allergy Capitals, which lists the top 100 cities for allergies. Greensboro, N.C.; Johnson City, Tenn.; Augusta, Ga.; and Jackson, Miss. Follow Lexington in the top five. Spokane, Wash.; San Francisco, Cal.; Bakersfield, Cal.; Sarasota, Fla.; and Lancaster, Penn.

  • Inspire To Discontinue Development Of Epinastine Nasal Spray
    Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis (SAR) did not meet its primary endpoint. "Our analysis of the overall data in this program and the current competitive environment in allergic rhinitis indicate that epinastine nasal spray does not show potential to meet our desired product profile in the United States," stated Christy L. Shaffer, Ph.D.

  • FDA Clears Glove Made From New Type Of Latex
    The U.S. Food and Drug Administration has cleared for marketing the first device made from a new form of natural rubber latex, guayule latex. The product, the Yulex Patient Examination Glove, is derived from the guayule bush, a desert plant native to the Southwestern United States.Traditional latex gloves are made from the milky sap of a rubber tree, Hevea braziliensis.

  • Keep An Eye On Allergies This Season
    An estimated 50 million Americans suffer from the miseries of allergies, with allergic reactions involving the eyes a common complaint. For many, symptoms of eye allergies can be so uncomfortable and irritating that they interfere with job performance, impede leisure-time and sports activities, and curtail vacations.


[ Back ]